||Epithelix Sàrl, provides alternative in vitro solutions to animal experimentation for evaluating the effects of drugs in development and assess the toxicity of chemical compounds on the human respiratory tract.
Epithelix is a biotech company founded in March 2006 and located in Geneva, Switzerland. Its founders are experienced scientists from University of Geneva with special expertise and know-how for in vitro reconstitutions of human and animal tissues. The company, being self-financed, proved its economic viability and invested in independent research and production facilities in December 2007. The company is the European leading provider of in vitro reconstituted human respiratory tissues and related services to leading academic research laboratory, Personnal Care, Medical Device, Chemical and Pharmaceutical.